Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Paul J. Rutgeerts, Leuven, Belgium – FDA Inspections
Company
•Belgium

Paul J. Rutgeerts, Leuven, Belgium – FDA Inspections

Inspection records and compliance data for Paul J. Rutgeerts in Leuven. 1 FDA inspection on record, last inspected April 22, 2016.

Sign in to open in Dashboard
Company Profile

This profile covers Paul J. Rutgeerts based in Leuven, Belgium.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected April 22, 2016.

FDA inspections (1)

DateResultFDA center(s)Insp. #
April 22, 2016NAIHuman Drugs · Bioresearch Monitoring971085
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Pfizer Clinical Research Unit, Hopital Erasme
Wim Van Paesschen
Frederic Vanhoutte, M.D.
Claus Bachert, M.D., Ph.D.
Le Conditionnement Belge
Dominik Selleslag
Ignace B. P. Vergote, MD, PhD
Luc Van Gaal
Frederik Nevens
Vertellus Specialties Belgium NV
Company Information

Name

Paul J. Rutgeerts

FEI Number

3002809211

Address

Academisch Ziekenhuis Gasthuisberg, Herestraat 49, Leuven, Belgium

Country

Belgium

ID: d8c642b8-4c32-46b0-98b9-efc4fd916277

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.